Fingerprint
Dive into the research topics of 'The novel BET-CBP/p300 dual inhibitor NEO2734 is active in SPOP mutant and wild-type prostate cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
The novel BET-CBP/p300 dual inhibitor NEO2734 is active in SPOP mutant and wild-type prostate cancer
Yuqian Yan, Jian Ma, Dejie Wang, Dong Lin, Xiaodong Pang, Shangqian Wang, Yu Zhao, Lei Shi, Hui Xue, Yunqian Pan, Jun Zhang, Claes Wahlestedt, Francis J. Giles, Yu Chen, Martin E. Gleave, Collin C. Collins, Dingwei Ye, Yuzhuo Wang, Haojie Huang
Research output: Contribution to journal › Article › peer-review
21
Scopus
citations